Core Viewpoint - The implementation plan for the high-quality development of the traditional Chinese medicine (TCM) industry from 2026 to 2030 aims to establish a collaborative development system for the entire TCM industry chain by 2030 [1] Group 1: Quality Improvement - The plan emphasizes the importance of improving the quality of raw materials by establishing high-standard production bases in major production areas [2] - Factors such as origin, climate, soil, and cultivation techniques significantly affect the quality of medicinal materials, which in turn impacts the therapeutic effects of TCM [2] - As of June 2025, China has supported artificial breeding of 14 endangered medicinal materials and has achieved industrial production of substitutes for rare materials [2] Group 2: Innovation and Collaboration - The plan proposes collaborative innovation initiatives to enhance the transformation of TCM preparations in medical institutions, focusing on overcoming technological bottlenecks [3] - A cooperative model involving renowned doctors, hospitals, schools, and enterprises is encouraged to integrate resources effectively [3] - The Beijing Daxing District's Guang'anmen Hospital has successfully transformed over 20 TCM varieties, with 4 of them becoming innovative TCM drugs [3] Group 3: Digital Transformation - The plan outlines actions to enhance manufacturing capabilities, including the establishment of 20 smart factories and the cultivation of 10 green factories [4] - The application of smart devices in the TCM industry is expected to facilitate the transition from traditional experience-based practices to precision-based methods [4] - The use of artificial intelligence and big data is aimed at constructing knowledge graphs for classic formulas and experiences from renowned TCM practitioners [4] Group 4: Future Outlook - The next five years are deemed critical for the transformation and upgrading of the TCM industry, with expectations for further modernization and high-quality development as the plan's measures are implemented [5]

Core Viewpoint - The implementation plan for the high-quality development of the traditional Chinese medicine (TCM) industry has been jointly issued by eight departments, aiming to establish a collaborative development system for the entire TCM industry chain by 2030 [1]. Group 1: Quality Improvement of Raw Materials - The plan emphasizes the importance of improving the quality of raw materials, proposing the establishment of high-standard production bases for TCM raw materials in major production areas [2]. - Factors such as origin, climate, soil, and cultivation techniques significantly influence the quality of medicinal materials, which directly affects the therapeutic effects of TCM [2]. - As of June 2025, China has supported the artificial breeding of 14 endangered medicinal materials, with over 300 out of 600 commonly used TCM materials already achieving artificial cultivation [2]. Group 2: Innovation and Transformation - The plan calls for collaborative innovation to promote the transformation of TCM preparations in medical institutions, addressing technological bottlenecks through cooperation among renowned doctors, hospitals, schools, and enterprises [3]. - Modern production lines in TCM facilities are being utilized for the mass production of hospital preparations, indicating a shift towards industrialized TCM [3]. Group 3: Digital and Intelligent Transformation - The plan proposes actions to enhance manufacturing capabilities, including the establishment of 20 smart factories and the cultivation of 10 green factories, alongside the revision of 10 industry standards related to digital technology in TCM [4]. - The application of smart devices in the TCM industry is expected to facilitate the transition from traditional experience-based practices to precision-based methods [4]. - The integration of artificial intelligence and big data is set to create knowledge graphs for classic formulas and experiences from renowned TCM practitioners, enhancing research and resource distribution in the field [4]. Group 4: Future Outlook - The next five years are identified as a critical period for the transformation and upgrading of the TCM industry, with expectations for further modernization and high-quality development as the proposed measures are implemented [5].

Group 1 - The core viewpoint of the news is the introduction of 137 key investment projects in Yunnan Province for 2026, with a total planned investment of 111.5 billion yuan, covering 16 prefectures and cities [1] - The projects align with the "4+5+6" modern industrial system, focusing on resource-based industries, characteristic advantageous industries, and strategic emerging industries [1] - Resource-based industries include 17 projects with a planned investment of 16.1 billion yuan, while characteristic advantageous industries have 64 projects with a planned investment of 57.26 billion yuan, and strategic emerging industries consist of 56 projects with a planned investment of 38.15 billion yuan [1] Group 2 - In Kunming, there are 12 projects, including a 5G data park and a digital economy industrial park, with a focus on a shareholding cooperation model for the high-end pharmaceutical industry [2] - The investment opportunities list released by Yunnan Province outlines the region's comparative advantages in resources, location, industry, and openness, providing a clear guide for enterprises [3] - The comparative advantage list includes 28 key areas showcasing Yunnan's resource endowment and development potential, emphasizing its rich mineral resources and strategic location for cross-border logistics [3] Group 3 - The project list targeting private capital covers 343 projects across 11 key sectors, with a total investment of 223.12 billion yuan, balancing public welfare and commercial viability [4]

Core Viewpoint - The implementation plan for the high-quality development of traditional Chinese medicine (TCM) industry aims to establish a collaborative development system by 2030, enhancing the supply capacity of key TCM raw materials and promoting innovation in TCM products [1][2] Group 1: Development Goals - By 2030, the TCM industry is expected to form a collaborative development system across the entire industry chain, with a focus on enhancing the stable supply of key TCM raw materials and improving digital and green levels [1] - The plan includes the cultivation of 60 high-standard TCM raw material production bases and the establishment of five TCM industrial innovation centers [1] Group 2: Innovation and Market Trends - The plan emphasizes the need for continuous innovation in TCM products, aiming to approve a batch of innovative TCM drugs and cultivate 10 major varieties of traditional Chinese medicine [2] - Companies are encouraged to shift from "sales-driven" to "innovation-driven" strategies to enhance their core competitiveness in a market characterized by homogenization [2] Group 3: Research and Development Requirements - TCM companies are required to conduct high-level evidence-based medical research to provide clear efficacy and safety data, targeting unmet medical needs for precise treatment [2] - Establishing a comprehensive digital quality control system from raw materials to finished products is essential for ensuring product reliability [2] Group 4: Digital Transformation - The plan highlights the importance of "digital intelligence" in transforming the TCM industry from traditional practices to modern scientific management [4][5] - Emphasizing digital intelligence aims to standardize and optimize production processes, ensuring consistent product quality and meeting regulatory requirements [6] Group 5: Support for Industry Leaders - The plan proposes actions to cultivate outstanding enterprises in the TCM industry, supporting leading companies in establishing development funds and providing financial services [6] - It encourages the formation of innovation consortia to drive technological advancements and improve the overall modernization level of the TCM industry [6]

Core Viewpoint - The "Implementation Plan for High-Quality Development of Traditional Chinese Medicine Industry (2026-2030)" aims to establish a collaborative development system for the entire industry chain by 2030, enhancing the stable supply of key raw materials, improving digital and green transformation levels, achieving breakthroughs in key technologies, and significantly increasing collaborative innovation levels [3][14]. Group 1: Development Goals - The plan sets four main goals: improving development quality, enhancing collaborative systems, fostering innovative products, and achieving breakthroughs in digital and green transformation [4][15]. - Specific tasks include cultivating 60 high-standard raw material production bases and establishing five innovation centers for the traditional Chinese medicine industry [4][15]. - The plan aims to promote the approval of innovative traditional Chinese medicine drugs and develop 10 major new traditional Chinese medicine products [4][15]. Group 2: Specific Actions - The plan outlines 15 specific tasks focusing on actions such as improving raw material quality and supply, collaborative innovation, enhancing manufacturing capabilities, revitalizing the national medicine industry, promoting traditional Chinese medicine products, and nurturing outstanding enterprises [5][16]. - It emphasizes the establishment of high-standard raw material production bases and the development of intelligent circulation and storage management systems for traditional Chinese medicine materials [7][18]. Group 3: Innovation and Technology - The plan encourages the use of artificial intelligence and big data to enhance the research and development of traditional Chinese medicine, including the creation of knowledge graphs for classic formulas and experiences from renowned practitioners [9][20]. - It also supports the clinical trials of new traditional Chinese medicine drugs and aims to shorten the research and development cycle while reducing costs [9][20]. Group 4: Market and Brand Development - The plan includes initiatives to protect intellectual property rights for traditional brands and improve the production processes of existing traditional Chinese medicine products to enhance their clinical and market value [6][17]. - It encourages collaboration between traditional Chinese medicine enterprises and e-commerce platforms to provide efficient purchasing experiences for patients [6][17].

Core Viewpoint - The article discusses the "Implementation Plan for the High-Quality Development of Traditional Chinese Medicine Industry (2026-2030)" issued by the Ministry of Industry and Information Technology and other departments, outlining goals for the development of the traditional Chinese medicine (TCM) industry over the next five years, focusing on supply stability, innovation, and digital transformation [1][3]. Group 1: Development Goals - The plan sets four major goals for the TCM industry by 2030, including the establishment of a collaborative development system, enhanced supply capabilities of key TCM raw materials, significant improvements in digital and green levels, and breakthroughs in key technologies [1][3]. - Specific tasks include improving the quality of TCM production, enhancing the collaborative system across the supply chain, and promoting the continuous emergence of innovative TCM products [3][5]. Group 2: Specific Actions - The plan outlines 15 specific tasks across six action areas, including actions to ensure stable supply of raw materials, promote collaborative innovation, enhance manufacturing capabilities, and revitalize the national medicine industry [5][9]. - For TCM raw materials, the plan emphasizes the construction of high-standard production bases and the establishment of a smart circulation and storage management system to ensure stable supply [7][9]. Group 3: Innovation and Product Development - The plan aims to foster the development of innovative TCM products, including the approval of new TCM drugs and the cultivation of major TCM varieties [3][5]. - It encourages collaboration between TCM enterprises and e-commerce platforms to enhance patient access to TCM products and improve the clinical and market value of TCM [5][9]. Group 4: Quality and Standards - The plan includes actions to enhance the quality standards of TCM, such as the formulation of national standards for TCM decoction pieces and the establishment of a quality traceability system [8][9]. - It also highlights the importance of protecting intellectual property rights for traditional brands and improving production processes for existing TCM products [5][9].

Core Viewpoint - The Ministry of Industry and Information Technology and seven other departments have jointly issued the "Implementation Plan for the High-Quality Development of Traditional Chinese Medicine Industry (2026-2030)", aiming to establish a collaborative development system for the entire traditional Chinese medicine industry chain by 2030 [1][2] Group 1: Goals and Objectives - By 2030, the plan aims to enhance the stable supply capacity of key traditional Chinese medicine raw materials and significantly improve the levels of digitalization and greening [1] - The plan includes cultivating a number of leading enterprises in the traditional Chinese medicine industry and establishing 60 high-standard raw material production bases [1] - It targets the approval and market launch of a batch of innovative traditional Chinese medicine products, including the cultivation of 10 major traditional Chinese medicine varieties [1][2] Group 2: Implementation Strategies - The plan outlines six key areas with 15 tasks, focusing on stabilizing supply, collaborative innovation, intelligent manufacturing, product promotion, and service system construction [1] - It emphasizes the need to revise production technology specifications and quality standards for key processing links in traditional Chinese medicine [2] - The use of artificial intelligence and big data to construct knowledge graphs for classic formulas and experiences from renowned traditional Chinese medicine practitioners is highlighted [1][2] Group 3: Quality Control and International Cooperation - The plan includes the establishment of a comprehensive quality control system and the development of new products from advantageous ethnic medicines [2] - It aims to enhance the clinical and market value of traditional Chinese medicine products and encourages international registration of advantageous traditional Chinese medicine products [2] - The plan calls for integrating related tasks into the high-quality development action system of key manufacturing industry chains [2]

Core Viewpoint - The "Implementation Plan for High-Quality Development of Traditional Chinese Medicine Industry (2026-2030)" aims to establish a collaborative development system for the entire TCM industry chain by 2030, enhancing the supply capacity of key TCM raw materials, and significantly improving digitalization and greening levels [2]. Group 1: Development Goals - The plan sets four major goals: improving development quality, enhancing collaborative systems, fostering innovative products, and achieving breakthroughs in digital and green transformation [3]. - Specific tasks include increasing the scale and efficiency of the TCM industry, cultivating 60 high-standard TCM raw material production bases, and establishing five TCM industrial innovation centers [3][4]. Group 2: Collaborative Innovation and Raw Material Supply - The plan emphasizes the importance of stable raw material supply as a cornerstone for the industry, proposing the construction of high-standard raw material production bases and enhancing the monitoring and information service platform for TCM raw materials [6][8]. - It also outlines actions for collaborative innovation, including strengthening the transformation and application of scientific research achievements in TCM and promoting the use of AI and big data in TCM new drug development [8]. Group 3: Product Innovation and Market Promotion - The plan aims to promote the approval and market entry of innovative TCM products, including the cultivation of 10 major new TCM products and enhancing the clinical and market value of existing TCM formulations [4][5]. - It encourages collaboration between TCM companies and e-commerce platforms to improve patient access to TCM products [5]. Group 4: Manufacturing and Quality Standards - The plan includes actions to enhance manufacturing capabilities and establish national standards for TCM decoction pieces and formula granules, aiming for a more standardized production process [7]. - It also focuses on improving the quality traceability system for TCM production and distribution, ensuring the integrity of the supply chain [7].

Core Insights - The Ministry of Industry and Information Technology and seven other departments have jointly issued the "Implementation Plan for the High-Quality Development of Traditional Chinese Medicine Industry (2026-2030)" which aims to establish a collaborative development system for the entire industry chain by 2030 [1] Group 1: Development Goals - By 2030, the plan aims to enhance the stable supply capacity of key traditional Chinese medicine raw materials and significantly improve the levels of digitalization and greening [1] - The plan includes the cultivation of 60 high-standard traditional Chinese medicine raw material production bases and the establishment of five innovation centers for the traditional Chinese medicine industry [1] Group 2: Innovation and Product Development - The plan emphasizes the continuous emergence of innovative products, aiming to approve a batch of innovative traditional Chinese medicines and cultivate 10 major varieties of traditional Chinese medicine [2] - Companies are encouraged to shift from "sales-driven" to "innovation-driven" strategies to overcome homogenization in the market [2] Group 3: Clinical and Research Requirements - Companies need to conduct high-level evidence-based medical research to provide clear efficacy and safety data, targeting unmet medical needs for precise treatment [2] - A comprehensive digital quality control system from raw materials to finished products is essential to ensure product reliability [2] Group 4: Digital Transformation - The plan highlights the importance of "digitalization" as a key strategic choice for transforming the traditional Chinese medicine industry from traditional experience-based models to modern scientific management [4] - Emphasizing digitalization aims to address internal pain points, meet regulatory requirements, and build a future-oriented industrial ecosystem [5] Group 5: Support for Enterprises - The plan proposes actions to cultivate outstanding enterprises, supporting leading companies in the traditional Chinese medicine industry to establish development funds and improve governance structures [5] - It encourages the establishment of innovation consortia to drive technological innovation in the traditional Chinese medicine sector [5]

Core Viewpoint - The "Implementation Plan for the High-Quality Development of Traditional Chinese Medicine Industry (2026-2030)" aims to establish a collaborative development system for the entire industry chain of traditional Chinese medicine by 2030, enhancing supply capabilities, technological breakthroughs, and innovation levels [1][2]. Group 1: Industry Development Goals - By 2030, the plan targets the emergence of innovative products, approval of new traditional Chinese medicine drugs, and the cultivation of 10 major traditional Chinese medicine varieties [2][3]. - The plan emphasizes the establishment of 60 high-standard raw material production bases and the construction of 5 innovation centers for traditional Chinese medicine [1][2]. Group 2: Strategic Focus Areas - Companies are encouraged to build full-chain capabilities centered on clinical value to overcome homogenization in the market, shifting from "sales-driven" to "innovation-driven" approaches [2][3]. - Emphasis on conducting high-level evidence-based medical research to provide differentiated academic evidence for products [2][3]. Group 3: Digital Transformation - The plan highlights the importance of "digital intelligence" in transitioning the traditional medicine industry from experience-based practices to modern scientific management [4][5]. - Key strategies include establishing digital quality control systems and intelligent factories to ensure product quality and compliance with regulatory standards [5][6]. Group 4: Support for Enterprises - The plan proposes actions to cultivate outstanding enterprises, including establishing development funds and providing financial services to traditional Chinese medicine companies [6]. - It aims to enhance the competitiveness of small and medium-sized enterprises in the sector and promote their modernization [6].